Sabra Healthcare REIT (NASDAQ:SBRA) Announces Quarterly Earnings Results

Key Points

• Sabra Healthcare REIT reported earnings of $0.38 EPS for the quarter, surpassing analysts' expectations of $0.37 by $0.01.
• Following the earnings release, the company updated its FY 2025 guidance to $1.450-1.470 EPS.
• Scotiabank raised its price target for Sabra Healthcare REIT from $19.00 to $20.00, maintaining a "sector perform" rating on the stock.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) issued its earnings results on Monday. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.36 by $0.02, Zacks reports. Sabra Healthcare REIT had a return on equity of 5.14% and a net margin of 19.55%. During the same period last year, the business posted $0.36 earnings per share. The company's revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT updated its FY 2025 guidance to 1.450-1.470 EPS.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock traded up $0.12 during trading on Monday, hitting $18.41. 3,057,108 shares of the stock were exchanged, compared to its average volume of 2,427,349. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.22 and a current ratio of 4.22. Sabra Healthcare REIT has a 12 month low of $15.60 and a 12 month high of $20.03. The stock's fifty day moving average is $18.14 and its 200 day moving average is $17.50. The stock has a market cap of $4.38 billion, a PE ratio of 31.20, a P/E/G ratio of 1.52 and a beta of 0.86.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the sale, the director owned 64,725 shares in the company, valued at approximately $1,179,289.50. This trade represents a 14.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.10% of the stock is owned by insiders.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Sabra Healthcare REIT stock. Focus Partners Wealth grew its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 11.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,146 shares of the real estate investment trust's stock after purchasing an additional 2,375 shares during the period. Focus Partners Wealth's holdings in Sabra Healthcare REIT were worth $404,000 as of its most recent SEC filing. 99.40% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Scotiabank lifted their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $19.67.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.